SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-132125
Filing Date
2020-12-03
Accepted
2020-12-03 20:42:02
Documents
2
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 4356
2 EX-24 ex-24.htm EX-24 9835
  Complete submission text file 0001104659-20-132125.txt   15528
Mailing Address 1177 AVENUE OF THE AMERICAS, F140 NEW YORK NY 10036
Business Address
Reicin Glenn (Reporting) CIK: 0001790218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39746 | Film No.: 201368369

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations